208 related articles for article (PubMed ID: 31543975)
1. Risk of diabetes associated with fatty acids in the de novo lipogenesis pathway is independent of insulin sensitivity and response: the Insulin Resistance Atherosclerosis Study (IRAS).
Qureshi W; Santaren ID; Hanley AJ; Watkins SM; Lorenzo C; Wagenknecht LE
BMJ Open Diabetes Res Care; 2019; 7(1):e000691. PubMed ID: 31543975
[TBL] [Abstract][Full Text] [Related]
2. Prospective association of fatty acids in the de novo lipogenesis pathway with risk of type 2 diabetes: the Cardiovascular Health Study.
Ma W; Wu JH; Wang Q; Lemaitre RN; Mukamal KJ; Djoussé L; King IB; Song X; Biggs ML; Delaney JA; Kizer JR; Siscovick DS; Mozaffarian D
Am J Clin Nutr; 2015 Jan; 101(1):153-63. PubMed ID: 25527759
[TBL] [Abstract][Full Text] [Related]
3. Serial Biomarkers of De Novo Lipogenesis Fatty Acids and Incident Heart Failure in Older Adults: The Cardiovascular Health Study.
Lee Y; Lai HTM; de Oliveira Otto MC; Lemaitre RN; McKnight B; King IB; Song X; Huggins GS; Vest AR; Siscovick DS; Mozaffarian D
J Am Heart Assoc; 2020 Feb; 9(4):e014119. PubMed ID: 32020839
[TBL] [Abstract][Full Text] [Related]
4. Circulating de novo lipogenesis fatty acids and all-cause mortality in a prospective Dutch population cohort.
Zhu Y; Vogelpohl FA; Heiner-Fokkema MR; Pranger IG; Minović I; Navis GJ; Bakker SJL; Riphagen IJ
J Clin Lipidol; 2022; 16(5):658-666. PubMed ID: 35909048
[TBL] [Abstract][Full Text] [Related]
5. Associations of erythrocyte fatty acids in the de novo lipogenesis pathway with risk of metabolic syndrome in a cohort study of middle-aged and older Chinese.
Zong G; Zhu J; Sun L; Ye X; Lu L; Jin Q; Zheng H; Yu Z; Zhu Z; Li H; Sun Q; Lin X
Am J Clin Nutr; 2013 Aug; 98(2):319-26. PubMed ID: 23803879
[TBL] [Abstract][Full Text] [Related]
6. Fatty acids in the de novo lipogenesis pathway and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies.
Imamura F; Fretts AM; Marklund M; Ardisson Korat AV; Yang WS; Lankinen M; Qureshi W; Helmer C; Chen TA; Virtanen JK; Wong K; Bassett JK; Murphy R; Tintle N; Yu CI; Brouwer IA; Chien KL; Chen YY; Wood AC; Del Gobbo LC; Djousse L; Geleijnse JM; Giles GG; de Goede J; Gudnason V; Harris WS; Hodge A; Hu F; ; Koulman A; Laakso M; Lind L; Lin HJ; McKnight B; Rajaobelina K; Riserus U; Robinson JG; Samieri C; Senn M; Siscovick DS; Soedamah-Muthu SS; Sotoodehnia N; Sun Q; Tsai MY; Tuomainen TP; Uusitupa M; Wagenknecht LE; Wareham NJ; Wu JHY; Micha R; Lemaitre RN; Mozaffarian D; Forouhi NG
PLoS Med; 2020 Jun; 17(6):e1003102. PubMed ID: 32530938
[TBL] [Abstract][Full Text] [Related]
7. Serial Plasma Phospholipid Fatty Acids in the De Novo Lipogenesis Pathway and Total Mortality, Cause-Specific Mortality, and Cardiovascular Diseases in the Cardiovascular Health Study.
Lai HTM; de Oliveira Otto MC; Lee Y; Wu JHY; Song X; King IB; Psaty BM; Lemaitre RN; McKnight B; Siscovick DS; Mozaffarian D
J Am Heart Assoc; 2019 Nov; 8(22):e012881. PubMed ID: 31711385
[TBL] [Abstract][Full Text] [Related]
8. Reduction of De Novo Lipogenesis Mediates Beneficial Effects of Isoenergetic Diets on Fatty Liver: Mechanistic Insights from the MEDEA Randomized Clinical Trial.
Costabile G; Della Pepa G; Salamone D; Luongo D; Naviglio D; Brancato V; Cavaliere C; Salvatore M; Cipriano P; Vitale M; Corrado A; Rivellese AA; Annuzzi G; Bozzetto L
Nutrients; 2022 May; 14(10):. PubMed ID: 35631319
[TBL] [Abstract][Full Text] [Related]
9. Markers of de novo lipogenesis in adipose tissue: associations with small adipocytes and insulin sensitivity in humans.
Roberts R; Hodson L; Dennis AL; Neville MJ; Humphreys SM; Harnden KE; Micklem KJ; Frayn KN
Diabetologia; 2009 May; 52(5):882-90. PubMed ID: 19252892
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide association study identifies novel loci associated with concentrations of four plasma phospholipid fatty acids in the de novo lipogenesis pathway: results from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium.
Wu JH; Lemaitre RN; Manichaikul A; Guan W; Tanaka T; Foy M; Kabagambe EK; Djousse L; Siscovick D; Fretts AM; Johnson C; King IB; Psaty BM; McKnight B; Rich SS; Chen YD; Nettleton JA; Tang W; Bandinelli S; Jacobs DR; Browning BL; Laurie CC; Gu X; Tsai MY; Steffen LM; Ferrucci L; Fornage M; Mozaffarian D
Circ Cardiovasc Genet; 2013 Apr; 6(2):171-83. PubMed ID: 23362303
[TBL] [Abstract][Full Text] [Related]
11. Association of erythrocyte membrane fatty acids with changes in glycemia and risk of type 2 diabetes.
Mahendran Y; Ågren J; Uusitupa M; Cederberg H; Vangipurapu J; Stančáková A; Schwab U; Kuusisto J; Laakso M
Am J Clin Nutr; 2014 Jan; 99(1):79-85. PubMed ID: 24153340
[TBL] [Abstract][Full Text] [Related]
12. Fatty acids in the de novo lipogenesis pathway and risk of coronary heart disease: the Cardiovascular Health Study.
Wu JH; Lemaitre RN; Imamura F; King IB; Song X; Spiegelman D; Siscovick DS; Mozaffarian D
Am J Clin Nutr; 2011 Aug; 94(2):431-8. PubMed ID: 21697077
[TBL] [Abstract][Full Text] [Related]
13. Hepatic saturated fatty acid fraction is associated with de novo lipogenesis and hepatic insulin resistance.
Roumans KHM; Lindeboom L; Veeraiah P; Remie CME; Phielix E; Havekes B; Bruls YMH; Brouwers MCGJ; Ståhlman M; Alssema M; Peters HPF; de Mutsert R; Staels B; Taskinen MR; Borén J; Schrauwen P; Schrauwen-Hinderling VB
Nat Commun; 2020 Apr; 11(1):1891. PubMed ID: 32312974
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal associations of serum fatty acid composition with type 2 diabetes risk and markers of insulin secretion and sensitivity in the Finnish Diabetes Prevention Study.
Takkunen MJ; Schwab US; de Mello VD; Eriksson JG; Lindström J; Tuomilehto J; Uusitupa MI;
Eur J Nutr; 2016 Apr; 55(3):967-79. PubMed ID: 25930966
[TBL] [Abstract][Full Text] [Related]
15. Reduction in liver fat by dietary MUFA in type 2 diabetes is helped by enhanced hepatic fat oxidation.
Bozzetto L; Costabile G; Luongo D; Naviglio D; Cicala V; Piantadosi C; Patti L; Cipriano P; Annuzzi G; Rivellese AA
Diabetologia; 2016 Dec; 59(12):2697-2701. PubMed ID: 27650287
[TBL] [Abstract][Full Text] [Related]
16. Serum pentadecanoic acid (15:0), a short-term marker of dairy food intake, is inversely associated with incident type 2 diabetes and its underlying disorders.
Santaren ID; Watkins SM; Liese AD; Wagenknecht LE; Rewers MJ; Haffner SM; Lorenzo C; Hanley AJ
Am J Clin Nutr; 2014 Dec; 100(6):1532-40. PubMed ID: 25411288
[TBL] [Abstract][Full Text] [Related]
17. Clusters of adipose tissue dysfunction in adults with type 2 diabetes identify those with worse lipidomic profile despite similar glycaemic control.
Della Pepa G; Carli F; Sabatini S; Pezzica S; Russo M; Vitale M; Masulli M; Riccardi G; Rivellese AA; Vaccaro O; Bozzetto L; Gastaldelli A
Diabetes Metab Res Rev; 2024 May; 40(4):e3798. PubMed ID: 38558269
[TBL] [Abstract][Full Text] [Related]
18. Supplemental palmitoleic (C16:1 cis-9) acid reduces lipogenesis and desaturation in bovine adipocyte cultures.
Burns TA; Duckett SK; Pratt SL; Jenkins TC
J Anim Sci; 2012 Oct; 90(10):3433-41. PubMed ID: 22851248
[TBL] [Abstract][Full Text] [Related]
19. Circulating omega-7 fatty acids are differentially related to metabolic dysfunction and incident type II diabetes: The Multi-Ethnic Study of Atherosclerosis (MESA).
Weir NL; Steffen BT; Guan W; Johnson LM; Djousse L; Mukamal KJ; Tsai MY
Diabetes Metab; 2020 Sep; 46(4):319-325. PubMed ID: 31706030
[TBL] [Abstract][Full Text] [Related]
20. Desaturation index versus isotopically measured de novo lipogenesis as an indicator of acute systemic lipogenesis.
Harding SV; Bateman KP; Kennedy BP; Rideout TC; Jones PJ
BMC Res Notes; 2015 Feb; 8():49. PubMed ID: 25879456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
